MSB 7.69% $1.19 mesoblast limited

Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial, page-70

  1. 1,972 Posts.
    lightbulb Created with Sketch. 859
    I have to agree with you on exposure. Even the GVHD did not get a mention in the Australian media. I note than Channel 9 regularly features medical breakthroughs by Australian researchers and scientist and not once has MSB been featured. Shouldn't the Corporate Communication Manager be actively pushing for exposure and worldwide media coverage rather than the odd announcements.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.